Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Birth Control Health Center

Font Size

New Birth Control Pill Natazia Gets FDA Approval

Combination Hormone Tablet Already in Use in Europe
WebMD Health News
Reviewed by Laura J. Martin, MD

May 13, 2010 -- The FDA says it has approved a new birth control pill called Natazia that is the first four-phase oral contraceptive to be marketed in the United States.

The pill, manufactured by Bayer HealthCare Pharmaceuticals of Wayne, N.J., contains two female hormones -- an estrogen called estradiol valerate and a progestin called dienogest.

Natazia already has been licensed in Europe under the brand name Qlaira.

The FDA says “four-phasic” means the pill delivers varying doses of the progestin and estrogen at four times throughout each 28-day treatment cycle.

“Nearly 12 million women in the United States and more than 100 million women worldwide currently use oral contraceptives,” Scott Monroe, MD, director of FDA’s Division of Reproductive and Urologic Products, says in a news release. “The approval of Natazia provides another option for women who choose to use an oral contraceptive as their method of contraception.”

The FDA says two studies of 1,867 women found Natazia effective.

Irregular bleeding is one of the most common side effects of Natazia.

Others include breast tenderness, headaches, nausea and vomiting, increased weight, and acne.

The FDA says women older than 35 who smoke should not use Natazia, and cautioned that smoking cigarettes increases the risk of serious cardiovascular events for women using oral contraceptives. Birth control pills do not protect against sexually transmitted diseases, including HIV (the virus that causes AIDS).

Birth control pills have been available for 50 years, but Bayer says Natazia is the first in a new class of oral contraceptives to deliver estradiol valerate, a synthetic estrogen.

“We are very pleased that now women in the U.S. have the option to choose our new oral contraceptive Natazia as an effective option for the prevention of pregnancy,” said Bayer’s Phil Smits, MD, in Berlin. “We are also working with the FDA on an indication for menstrual bleeding disorders to offer women a tailored therapy for this debilitating condition.”

Natazia is expected to be available in the U.S. this summer, Bayer said in a news release issued at the parent company’s main office in Berlin.

Today on WebMD

Here's what to expect.
man opening condom wrapper
Do you know the right way to use them?
birth control pills
Here's what to do next.
doctor and patient
His and her options.
Concerned teenage girl
hospital gown
Birth Control Pills Weight Gain
pregnancy test and calendar
contraceptive pills
Young couple looking at each other, serious
woman reading pregnancy test result